Literature DB >> 8055177

Vaccines and cytokine-mediated pathology in RSV infection.

P C Doherty1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8055177     DOI： 10.1016/0966-842x(94)90662-9

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


× No keyword cloud information.
  4 in total

1.  Nasal vaccination induces protective immunity without immunopathology.

Authors:  T Hussell; I R Humphreys
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

2.  Modulation of protective immunity, eosinophilia, and cytokine responses by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial virus.

Authors:  Yan Huang; Robert Anderson
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse.

Authors:  Hsiao-Yun Shao; Yi-Wen Lin; Shu-Ling Yu; Hsiang-Yin Lin; Ebenezer Chitra; Yung-Chen Chang; Charles Sia; Pele Chong; Ming-Tao Hsu; Olivia L Wei; Yen-Hung Chow
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

4.  Protection against respiratory syncytial virus infection by DNA immunization.

Authors:  X Li; S Sambhara; C X Li; M Ewasyshyn; M Parrington; J Caterini; O James; G Cates; R P Du; M Klein
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.